Cost-effectiveness of Barrett's oesophagus screening and surveillance

Best Practice and Research: Clinical Gastroenterology

Volumn 27, Issue 6, 2013, Pages 893-903

  Gordon, Louisa G ^a   Mayne, George C ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Barrett's oesophagus; Cost effectiveness; Surveillance

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CHEMORADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE SURVEILLANCE; DNA CONTENT; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH STATUS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RISK ASSESSMENT;

EID: 84887175380     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2013.08.019     Document Type: Review

References (74)

1. N.J. Shaheen, and J.E. Richter Barrett's oesophagus Lancet 373 9666 2009 Mar 7 850 861
2. R. Garside, M. Pitt, M. Somerville, K. Stein, A. Price, and N. Gilbert Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling Health Technol Assess 10 8 2006 Mar 1 158
3. J.H. Rubenstein, N. Mattek, and G. Eisen Age- and sex-specific yield of Barrett's esophagus by endoscopy indication Gastrointest Endosc 71 2010 21 27
4. P. Sharma, G.W. Falk, A.P. Weston, D. Reker, M. Johnston, and R.E. Sampliner Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 5 2006 May 566 572 (Pubitemid 44308164)
5. K.J. Smith, S.M. O'Brien, B.M. Smithers, D.C. Gotley, P.M. Webb, and A.C. Green Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 14 11 Pt 1 2005 Nov 2481 2486 (Pubitemid 41752705)
6. D.C. Whiteman, S. Sadeghi, N. Pandeya, B.M. Smithers, D.C. Gotley, and C.J. Bain Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus Gut 57 2 2008 Feb 173 180 (Pubitemid 351158042)
7. S. Sadeghi, C.J. Bain, N. Pandeya, P.M. Webb, A.C. Green, and D.C. Whiteman Aspirin, non-steroidal anti-inflammatory drugs, and the risks of cancers of the esophagus Cancer epidemiol, Biomarkers Prev 17 5 2008 1169 1178
8. H.D. Appelman, A. Umar, R.C. Orlando, S.J. Sontag, S. Nandurkar, and H. El-Zimaity Barrett's esophagus: natural history Ann N Y Acad Sci 1232 2011 Sep 292 308
9. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 3 2008 Mar 788 797 (Pubitemid 351406009)
10. A. Watson, R.C. Heading, and N.A. Shepherd Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus 2005 British Society of Gastroenterology Loughborough
11. M. Sikkema, P.J. de Jonge, E.W. Steyerberg, and E.J. Kuipers Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 8 3 2010 Mar 235 244 quiz e32
12. W. Hameeteman, G.N. Tytgat, H.J. Houthoff, and J.G. van den Tweel Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 5 Pt 1 1989 May 1249 1256 (Pubitemid 19126659)
13. J.B. O'Connor, G.W. Falk, and J.E. Richter The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the cleveland clinic Barrett's esophagus registry Am J Gastroenterol 94 8 1999 Aug 2037 2042 (Pubitemid 29374529)
14. L. Murray, P. Watson, B. Johnston, J. Sloan, I.M. Mainie, and A. Gavin Risk of adenocarcinoma in Barrett's oesophagus: population based study BMJ (Clinical Research Ed) 327 7414 2003 Sep 6 534 535 (Pubitemid 37088499)
15. K.K. Basu, B. Pick, and J.S. de Caestecker Audit of a Barrett's epithelium surveillance database Eur J Gastroenterol Hepatol 16 2 2004 Feb 171 175 (Pubitemid 39049653)
16. C.P. Caygill, P.I. Reed, M.J. Hill, and A. Watson An initial comparison of nine centres registering patients with the UK National Barrett's Oesophagus Registry (UKBOR) Eur J Cancer Prev 8 6 1999 Dec 539 542 (Pubitemid 30019694)
17. N. Shaheen, and D.F. Ransohoff Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review JAMA 287 15 2002 Apr 17 1972 1981 (Pubitemid 34326418)
18. C. Bennett, N. Vakil, J. Bergman, R. Harrison, R. Odze, and M. Vieth Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process Gastroenterology 143 2 2012 Aug 336 346
19. M. Kerkhof, H. van Dekken, E.W. Steyerberg, G.A. Meijer, A.H. Mulder, and A. de Bruine Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists Histopathology 50 7 2007 Jun 920 927 (Pubitemid 46850080)
20. M. Skacel, R.E. Petras, T.L. Gramlich, J.E. Sigel, J.E. Richter, and J.R. Goldblum The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression Am J Gastroenterol 95 12 2000 Dec 3383 3387
21. E. Montgomery, M.P. Bronner, J.R. Goldblum, J.K. Greenson, M.M. Haber, and J. Hart Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 4 2001 Apr 368 378 (Pubitemid 32378298)
22. P. Bampton, A. Schloithe, J. Bull, R. Padbury, and D. Watson Improving surveillance for Barrett's oesophagus BMJ 332 2006 1320 1323 (Pubitemid 44365390)
23. D.A. Corley, K. Mehtani, C. Quesenberry, W. Zhao, J. de Boer, and N.S. Weiss Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2 2013 Aug 312e1 319e1 10.1053/j.gastro.2013.05.004 [Epub 2013 May 11]
24. A.A. Stinnett, and J. Mullahy Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Making 18 2 Suppl. 1998 Apr-Jun S68 S80
25. S. Eckermann, A. Briggs, and A.R. Willan Health technology assessment in the cost-disutility plane Med Decis Making 28 2 2008 Mar-Apr 172 181 (Pubitemid 351441947)
26. Y.C. Shih, and M.T. Halpern Economic evaluations of medical care interventions for cancer patients: how, why, and what does it mean? CA Cancer J Clin 58 4 2008 Jul-Aug 231 244
27. L.G. Gordon, S. Eckermann, N.G. Hirst, D.I. Watson, G.C. Mayne, and P. Fahey Healthcare resource use and medical costs for the management of oesophageal cancer Br J Surg 98 11 2011 Nov 1589 1598
28. F. Hvid-Jensen, L. Pedersen, A.M. Drewes, H.T. Sorensen, and P. Funch-Jensen Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 15 2011 Oct 13 1375 1383
29. D. Provenzale, J.A. Kemp, S. Arora, and J.B. Wong A guide for surveillance of patients with Barrett's esophagus Am J Gastroenterol 89 5 1994 May 670 680 (Pubitemid 24132045)
30. L.G. Gordon, S. Eckermann, N.G. Hirst, D.I. Watson, G.C. Mayne, and P. Fahey Health care resource use and medical costs for managing oesophageal cancers Br J Surg 98 11 2011 Nov 1589 1598
31. A. Soni, and A. Sonnenberg Healthcare resource utilization in the management of oesophageal adenocarcinoma Aliment Pharmacol Ther 15 7 2001 Jul 945 951 (Pubitemid 32578965)
32. J. Moen, K. Antonov, C.A. Larsson, U. Lindblad, J.L.G. Nilsson, and L. Råstam Factors associated with multiple medication use in different age groups Pharmacoepidemiology 43 12 2009 1978 1985
33. L.G. Gordon, N.G. Hirst, G.C. Mayne, D.I. Watson, T. Bright, and W. Cai Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high grade dysplasia J Gastrointest Surg 16 8 2012 1451 1461
34. P.C. Boger, D. Turner, P. Roderick, and P. Patel A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus Aliment Pharmacol Ther 32 11-12 2010 Dec 1332 1342
35. H. Pohl, A. Sonnenberg, S. Strobel, A. Eckardt, and T. Rosch Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis Gastrointest Endosc 70 4 2009 Oct 623 631
36. J. Church, S. Goodall, S. Gurgacz, D.C. Whiteman, and R.V. Lord Cost-effectiveness of radiofrequency ablation compared to endoscopic surveillance for patients with Barrett's esophagus with low grade dysplasia Value Health 16 3 2013, May A215
37. M. Drummond, M.J. Sculpher, G.W. Torrance, B.J. O'Brien, and G.L. Stoddart Methods for the economic evaluation of health care programmes 2005 Oxford University Press Oxford
38. A.H. Briggs, K. Claxton, and M.J. Sculpher A. Gray, A.H. Briggs, Decision modelling for health economic evaluation 2006 Oxford University Press Oxford
39. J.M.G. Wilson, and G. Jungner Principles and practice of screening for disease 1968 World Health Organisation Geneva
40. J.M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A.M. Fendrick, and N. Vakil Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis Ann Intern Med 138 3 2003 Feb 4 176 186 (Pubitemid 36231623)
41. J.M. Barbiere, and G. Lyratzopoulos Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review Gastroenterology 137 6 2009 Dec 1869 1876
42. L. Gerson, and O.S. Lin Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus Clin Gastroenterol Hepatol 5 3 2007 Mar 319 325
43. L.B. Gerson, P.W. Groeneveld, and G. Triadafilopoulos Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease Clin Gastroenterol Hepatol 2 10 2004 Oct 868 879 (Pubitemid 39335793)
44. P.J. Nietert, M.D. Silverstein, M.S. Mokhashi, C.Y. Kim, T.F. Glenn, and V.A. Marsi Cost-effectiveness of screening a population with chronic gastroesophageal reflux Gastrointest Endosc 57 3 2003 Mar 311 318 (Pubitemid 36350785)
45. J.H. Rubenstein, J.M. Inadomi, J.V. Brill, and G.M. Eisen Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy Clin Gastroenterol Hepatol 5 3 2007 Mar 312 318 (Pubitemid 46401523)
46. T. Benaglia, L.D. Sharples, R.C. Fitzgerald, and G. Lyratzopoulos Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus Gastroenterology 144 1 2013 Jan 62 73 e6
47. N. Gupta, A. Bansal, S.B. Wani, S. Gaddam, A. Rastogi, and P. Sharma Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis Gastrointest Endosc 74 3 2011 Sep 610 624 e2
48. S. Bhat, H.G. Coleman, F. Yousef, B.T. Johnston, D.T. McManus, and A.T. Gavin Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 13 2011 Jul 6 1049 1057
49. T.K. Desai, K. Krishnan, N. Samala, J. Singh, J. Cluley, and S. Perla The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis Gut 61 7 2012 Jul 970 976 10.1136/gutjnl-2011-300730 [Epub 2011 Oct 13]
50. N.G. Hirst, L.G. Gordon, D.C. Whiteman, D.I. Watson, and J.J. Barendregt Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations J Gastroenterol Hepatol 26 2 2011 Feb 247 254
51. A. Das, C. Wells, H.J. Kim, D.E. Fleischer, M.D. Crowell, and V.K. Sharma An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus Endoscopy 41 5 2009 May 400 408
52. J.M. Inadomi, M. Somsouk, R.D. Madanick, J.P. Thomas, and N.J. Shaheen A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 7 2009 2101 2114
53. D. Provenzale, C. Schmitt, and J.B. Wong Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 8 1999 Aug 2043 2053 (Pubitemid 29374530)
54. A. Sonnenberg, and M.B. Fennerty Medical decision analysis of chemoprevention against esophageal adenocarcinoma Gastroenterology 124 7 2003 Jun 1758 1766 (Pubitemid 36666772)
55. A. Sonnenberg, A. Soni, and R.E. Sampliner Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma Aliment Pharmacol Ther 16 1 2002 Jan 41 50 (Pubitemid 34123863)
56. D. Husereau, M. Drummond, S. Petrou, C. Carswell, D. Moher, and D. Greenberg Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force Value Health J Int Soc Pharmacoeconomics Outcome Res 16 2 2013 Mar-Apr 231 250
57. N. Amamra, S. Touzet, C. Colin, and T. Ponchon Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus J Eval Clin Pract 13 5 2007 Oct 789 794 (Pubitemid 47373607)
58. J.A. Abrams, R.C. Kapel, G.M. Lindberg, M.H. Saboorian, R.M. Genta, and A.I. Neugut Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 13 2009 Jan 13 13
59. A. Meining, R. Ott, I. Becker, S. Hahn, J. Muhlen, and M. Werner The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only-what is the clinical significance? Gut 53 10 2004 Oct 1402 1407 (Pubitemid 39265256)
60. M. Alikhan, D. Rex, A. Khan, E. Rahmani, O. Cummings, and T.M. Ulbright Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice Gastrointest Endosc 50 1 1999 Jul 23 26 (Pubitemid 29323284)
61. S.L. Kim, J.P. Waring, S.J. Spechler, R.E. Sampliner, W.G. Doos, and W.F. Krol Diagnostic inconsistencies in Barrett's esophagus. Department of veterans affairs gastroesophageal reflux study group Gastroenterology 107 4 1994 Oct 945 949
62. P.C. Galipeau, X. Li, P.L. Blount, C.C. Maley, C.A. Sanchez, and R.D. Odze NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma PLoS Med 4 2 2007 Feb e67
63. T.T. Nguyen, S.E. Lakhan, and B.A. Finette Development of a cost-effective high-throughput process of microsatellite analysis involving miniaturized multiplexed PCR amplification and automated allele identification Hum Genomics 7 2013 6
64. E. Budinska, V. Popovici, S. Tejpar, G. D'Ario, N. Lapique, and K.O. Sikora Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer J Pathol 231 1 2013 Sep 63 76
65. A.M. Dulak, P. Stojanov, S. Peng, M.S. Lawrence, C. Fox, and C. Stewart Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity Nat Genet 45 5 2013 May 478 486
66. T.A. Graham, and S.A. McDonald Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why? Biochem Soc Trans 38 2 2010 Apr 374 379
67. L.M. Merlo, N.A. Shah, X. Li, P.L. Blount, T.L. Vaughan, and B.J. Reid A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma Cancer Prev Res (Phila) 3 11 2010 Nov 1388 1397
68. D.R. Fels Elliott, and R.C. Fitzgerald Molecular markers for Barrett's esophagus and its progression to cancer Curr Opin Gastroenterol 29 4 2013 Jul 437 445
69. P. Kountourakis, J.A. Ajani, M. Davila, J.H. Lee, M.S. Bhutani, and J.G. Izzo Barrett's esophagus: a review of biology and therapeutic approaches Gastrointest Cancer Res 5 2 2012 Mar 49 57
70. J.H. Rubenstein, N. Vakil, and J.M. Inadomi The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma Aliment Pharmacol Ther 22 2005 135 146 (Pubitemid 41039702)
71. J.R. Ramus, P.A. Gatenby, C.P. Caygill, M.C. Winslet, and A. Watson Surveillance of Barrett's columnar-lined oesophagus in the UK: endoscopic intervals and frequency of detection of dysplasia Eur J Gastroenterol Hepatol 21 6 2009 Jan 27 636 641
72. K.E. Corey, S.M. Schmitz, and N.J. Shaheen Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis Am J Gastroenterol 98 11 2003 Nov 2390 2394 (Pubitemid 37448746)
73. Y.M. Li, L. Li, C.H. Yu, Y.S. Liu, and C.F. Xu A systematic review and meta-analysis of the treatment for Barrett's esophagus Dig Dis Sci 53 11 2008 Nov 2837 2846
74. Gordon LG, Mayne GC, Hirst NG, Bright T, Whiteman DC, Australian Cancer Study Clinical Follow-Up Study, Watson DI. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus. Gastrointest Endosc. Available online 27 September 2013. ISSN 0016-5107. http://dx.doi.org/10.1016/j. gie.2013.07.046. [in press]